Order results by:
| Issue | Title | |
| Vol 16, No 6 (2024) | Updated and revised Russian consensus on the use of multilevel injections of abobotulinumtoxin A in children | Abstract similar documents |
| A. L. Kurenkov, O. A. Klochkova, V. A. Zmanovskaya, I. V. Falkovskiy, V. M. Kenis, L. N. Vladykina, D. A. Krasavina, A. S. Nosko, L. V. Rychkova, Kh. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, A. M. Mamedyarov, L. M. Kuzenkova, O. G. Dontzov, M. A. Ryzhenkov, M. N. Butorina, D. M. Dankov, E. V. Levitina, D. A. Popkov, S. O. Ryabykh, O. V. Agranovich, T. I. Kiseleva, O. N. Vasileva, V. P. Zykov, V. I. Mihnovich, T. A. Belogorova | ||
| "... . Clinical studies have shown the high efficacy of abobotulinumtoxin A in relieving spasticity of the lower ..." | ||
| Vol 2, No 3 (2010) | Treatment for spasticity after stroke | Abstract similar documents |
| S. E. Khatkova | ||
| "... for post-stroke spasticity therapy with botulinum, in particular botulinum toxin type A (Xeomin) used ..." | ||
| Vol 12, No 3 (2020) | Arm spasticity after stroke: botulinum toxin therapy in combination with multimodal stimulation | Abstract similar documents |
| V. N. Lutsik, E. V. Slyunkova, S. V. Kotov, V. K. Misikov, E. V. Biryukova | ||
| "... Post-stroke spasticity (PS) occurs in most patients with stroke and contributes to the development ..." | ||
| Vol 14, No 6 (2022) | Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice | Abstract similar documents |
| R. K. Shikhkerimov, E. V. Istomina | ||
| "... of the indications for the use of botulinum therapy in neurology is the correction of post-stroke spasticity ..." | ||
| Vol 14, No 2 (2022) | Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea | Abstract PDF (Eng) similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, B. I. Bursagova, V. V. Chernikov, O. V. Agranovich, L. G. Khachatryan, V. M. Kenis, V. A. Zherebtsova, M. N. Sarzhina, N. D. Odinaeva, A. R. Artemenko, G. A. Popova, E. A. Moroshek, E. E. Tabe, A. A. Nezhelskaya, A. A. Maksimenko, L. Ya. Akhadova, M. V. Indereikin, N. V. Duibanova, L. V. Tikhonova, A. V. Sapogovskiy, Z. M. Gadzhialieva, A. V. Grigorieva, V. S. Perminov, I. D. Fedonyuk, L. M. Kolpakchi, A. Yu. Kursakova, N. A. Tsurina | ||
| "... Botulinum therapy for cerebral palsy (CP) is considered not only as one of the effective ..." | ||
| Vol 16, No 1 (2024) | Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review) | Abstract similar documents |
| A. L. Kurenkov, B. I. Bursagova, A. R. Artemenko | ||
| "... Pain in cerebral palsy (CP) occurs in 30–60% of cases. Pain associated with spasticity (PAS ..." | ||
| Vol 8, No 2 (2016) | Ultrasound-guided botulinum toxin injections | Abstract similar documents |
| S. E. Khatkova, A. A. Balbert | ||
| "... One of the key conditions for achieving the desirable result during botulinum toxin therapy ..." | ||
| Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
| V. A. Parfenov | ||
| "... a leading role in the treatment of poststroke spasticity. The local administration of botulinum toxin ..." | ||
| Vol 8, No 4 (2016) | POSTSTROKE SPASTICITY: AN INDIVIDUALIZED APPROACH TO TREATMENT | Abstract similar documents |
| V. A. Tolmacheva | ||
| "... Poststroke spasticity is common in many patients and frequently hampers the recovery of lost motor ..." | ||
| Vol 13, No 5 (2021) | Spasticity syndrome in cerebral pathology: evaluation and clinical models | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, I. A. Voznyuk, V. K. Misikov | ||
| "... Knowing the frequency of spasticity patterns in different muscles allows correcting the botulinum ..." | ||
| Vol 16, No 2 (2024) | Modelling long-term outcomes and mortality risk in patients with post-stroke spasticity during abobotulinum toxin injections as part of rehabilitation | Abstract similar documents |
| S. E. Khatkova, A. S. Gilweg | ||
| "... of botulinum therapy (abobotulinum toxin injections – AboBTX) during rehabilitation in patients with post ..." | ||
| Vol 17, No 2 (2025) | 12-year experience of incobotulinumtoxinA use in neurological practice | Abstract similar documents |
| N. V. Kireeva, E. G. Bukreeva, D. S. Kireev | ||
| "... of secondary nonresponse. Results. BoNT-A therapy was most used for post-stroke spasticity (n=81), cervical ..." | ||
| Vol 14, No 1 (2022) | Treatment of spasticity in patients with the consequences of traumatic brain injury | Abstract similar documents |
| A. P. Kovalenko, I. A. Vozniuk, K. M. Naumov, V. Yu. Lobzin, S. Yu. Kirtaev | ||
| "... , data on the effectiveness of botulinum neurotoxin (BoNT) in the treatment of post-traumatic spasticity ..." | ||
| Vol 13, No 5 (2021) | Effectiveness of early abobotulinum toxin (Dysport®) injections in patients with upper limb spastic paresis after traumatic brain injury in real clinical practice: results of a multicenter observational non-interventional prospective study (Adults with post Traumatic Brain Injury (TBI) upper limb (UL) spasticity – APTULS) | Abstract similar documents |
| S. E. Khatkova, V. P. Diagileva, L. V. Krylova, D. V. Pokhabov, A. G. Arutiunian | ||
| "... ®) in patients with upper limb spasticity (ULS), which is one of disabling consequence traumatic's brain injuries ..." | ||
| Vol 9, No 3 (2017) | Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke | Abstract similar documents |
| V. V. Gusev, O. A. Lvova, T. V. Balueva | ||
| "... Objective: to evaluate the safety, efficacy, and tolerability of the botulinum toxin A Relatox ..." | ||
| Vol 12, No 6 (2020) | Mapping the limb muscle motor points for targeted administration of botulinum toxin in the treatment of focal and segmental spasticity | Abstract similar documents |
| A. P. Kovalenko, K. A. Sinelnikov, V. D. Shamigulov, N. N. Akhmedov, E. M. Shamina | ||
| "... Spasticity treatment remains an urgent problem of modern neurorehabilitation. The targeted ..." | ||
| Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
| S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
| "... Objective: to evaluate the safety and efficacy of the first Russian botulinum toxin-A relatox ..." | ||
| Vol 3, No 4 (2011) | Mechanisms in the pathogenesis of poststroke spasticity | Abstract similar documents |
| E. A. Katushkina, O. E. Zinovyeva, B. S. Shenkman, N. N. Yakhno | ||
| "... Objective: to study the mechanisms of poststroke spasticity and the role of structural ..." | ||
| Vol 13, No 2 (2021) | Gait rehabilitation in patients with spastic hemiparesis: new opportunities | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, A. S. Rodionov, D. I. Kremlyov, D. V. Averkiev, V. Yu. Lobzin, A. V. Guseva | ||
| "... the effectiveness of medical ESs and spasticity treatment for gait rehabilitation in patients with spastic ..." | ||
| Vol 12, No 5 (2020) | Cervical dystonia: current rehabilitation strategies and methods | Abstract similar documents |
| A. S. Istomina, I. V. Miliukhina, M. D. Didur | ||
| "... and pathogenesis of the disease. As a supplement to botulinum toxin therapy, a multimodal physiotherapy program ..." | ||
| Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
| V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
| "... stages. The efficacy of long-term botulinum therapy (BT) in CD has been poorly studied. Objective ..." | ||
| Vol 14, No 3 (2022) | Hemimasticatory spasm: possibilities of treatment with injections of botulinum neuroprotein type A (case report) | Abstract similar documents |
| L. U. Valieva, A. S. Pankratov, O. R. Orlova | ||
| "... with hemimasticatory spasm (HMS) with injections of botulinum neuroprotein type A (BNPA). The authors present ..." | ||
| Vol 4, No 1 (2012) | Neurotransmitters in the regulation of movements and in the development of spastic movement disorders | Abstract similar documents |
| Andrei Anatolyevich Korolev, G A Suslova | ||
| Vol 10, No 3 (2018) | Non-motor disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, M. R. Nodel, N. I. Saloukhna | ||
| "... Botulinum toxin injection therapy is the mainstay for managing patients with motor manifestations ..." | ||
| Vol 13, No 1 (2021) | Benign essential blepharospasm: epidemiology, clinical manifestations, pathophysiology, botulinum toxin therapy | Abstract similar documents |
| Z. A. Zalyalova | ||
| "... and sensorimotor disintegration. Botulinum toxin therapy is the most effective treatment for BPS. The advantage ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... of treatment (anti-CGRP mAbs, botulinum therapy) or when using combined therapy compared to monotherapy ..." | ||
| Vol 13, No 4 (2021) | IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy | Abstract similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko | ||
| "... , botulinum therapy can be an effective tool that significantly reduces sialorrhea manifestation. Oblective ..." | ||
| Vol 13, No 4 (2021) | Rehabilitation approaches in cervical dystonia | Abstract similar documents |
| Z. A. Zalyalova, E. R. Iusupova | ||
| "... disturbances, and pain. Current CD treatment guidelines include botulinum toxin (BT) injections as first-line ..." | ||
| Vol 8, No 2 (2016) | Possibilities of using computed tomography to treat mixed cervical dystonia with botulinum toxin type A | Abstract similar documents |
| T. V. Mokina, Yu. I. Pavlov, Z. A. Zalyalova | ||
| "... (CT) in the diagnosis and treatment of botulinum toxin type A (BTA) treatment of mixed cervical ..." | ||
| Vol 13, No 6 (2021) | Novel approaches to the treatment of cervical dystonia. The concept of dual navigation control | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, Z. A. Zalyalova, A. F. Ivolgin | ||
| "... ). Botulinum neurotoxin (BoNT) injections is the treatment choice for CD. However, the effectiveness ..." | ||
| Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
| "... and depressive manifestations. However, the change in the emotional state of patients with CD after botulinum ..." | ||
| Vol 12, No 4 (2020) | The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects | Abstract similar documents |
| R. G. Akzhigitov, K. I. Pochigayeva, F. K. Rider, A. M. Teplyshova, S. I. Dedayev, I. A. Shpak, E. V. Pashnin, A. B. Gekht | ||
| "... for the treatment of social diseases, such as epilepsy, pain syndromes, spasticity, including multiple sclerosis ..." | ||
| Vol 17, No 1 (2025) | Lower spastic paraplegia combined with hydromyelia | Abstract similar documents |
| E. G. Mendelevich, A. A. Kurbanova | ||
| "... of the spinal cord (hydromyelia). The development of slowly progressive muscle weakness and spasticity ..." | ||
| Vol 14, No 1 (2022) | The efficacy and safety of ipidacrine in patients with idiopathic neuropathy of the facial nerve (PELICAN study) | Abstract similar documents |
| I. N. Samartsev, S. A. Zhivolupov, V. V. Ponomarev, M. N. Markova, K. R. Magomedov | ||
| "... the number of patients with indications for botulinum therapy. Results and discussion. After six months ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... Objective: to evaluate the efficacy and safety of botulinum toxin type A (BTA) injections ..." | ||
| Vol 17, No 2 (2025) | Use of botulinum toxin in patients with dysphagia and sialorrhea in acute ischemic stroke | Abstract similar documents |
| V. V. Gusev, T. V. Balueva, O. V. Zayceva, D. A. Smirnov | ||
| "... and increase the risk of aspiration pneumonia. Botulinum toxin type A (BoNT-A) injections are effective ..." | ||
| Vol 11, No 3 (2019) | A case of segmental dystonia with mental/psychic nonmotor disorders | Abstract similar documents |
| V. A. Tolmacheva, D. V. Romanov, D. A. Grishina | ||
| "... of dystonia regressed during treatment with botulinum toxin; however, the patient did not report any ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| Vol 14, No 6 (2022) | The role of neurotrophic factors in the rehabilitation of children with cerebral palsy | Abstract similar documents |
| N. V. Larina, A. I. Gordienko, L. L. Korsunskaya, N. V. Khimich | ||
| "... -2”. The dynamics of the spasticity level, muscle strength in the paretic limbs, the level ..." | ||
| Vol 16, No 6 (2024) | Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy | Abstract similar documents |
| D. V. Zakharov, D. D. Kokareva | ||
| "... to correct their combination in Parkinson's disease with the possibility of reducing polypharmacy. Botulinum ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... in Republican Clinical Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy in Kazan from ..." | ||
| Vol 16, No 3 (2024) | Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... pathologies. It can be assumed that monoclonal antibodies against calcitonin gene-related peptides, botulinum ..." | ||
| Vol 9, No 2 (2017) | A multidisciplinary approach to treating musculoarticular dysfunction of the temporomandibular joint with obvious pain syndrome | Abstract similar documents |
| O. A. Shakhmetova, T. M. Sinitsina | ||
| "... dysfunction, by changing the biomechanical tempomandibular joint (TMJ) movement pattern via botulinum toxin ..." | ||
| Vol 5, No 1 (2013) | Neurological aspects of urinary incontinence in the elderly | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... , antidepressants, botulinum toxin preparations), methods for behavioral therapy and physiotherapy, and skin care ..." | ||
| Vol 10, No 1 (2018) | Cranial dystonia | Abstract similar documents |
| V. A. Tolmacheva | ||
| "... and from the receptors within it. Botulinum toxin preparations show the highest efficacy in treating ..." | ||
| Vol 16, No 3 (2024) | Isolated head tremor | Abstract similar documents |
| Z. A. Zalyalova, M. M. Ermakova, Z. G. Khayatova | ||
| "... of the tremor, the low efficacy of the drugs used for essential tremor and the use of botulinum neuroprotein ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... -blockers, angiotensin II receptor antagonists, botulinum toxin type A-hemagglutinin complex and monoclonal ..." | ||
| Vol 16 (2024): (Suppl. 2) | Pain in patients with neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. S. Novikova, A. S. Kotov, S. V. Kotov | ||
| "... (11 – AQP4+ and three – AQP4-), pain due to spasticity in 6 patients (5 – AQP4+ and 1 – AQP4 ..." | ||
| 1 - 48 of 48 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
